Expert: Continue Nusantara Vaccines With Scientific Research Publications

JAKARTA - Health expert Dr. Andreas Harry Lilisantoso, SpS (K) who is also a member of the "International Advance Research" of the International Alzheimer's Association (AAICAD) suggested that the Nusantara Vaccine should be continued, accompanied by scientific publications, both national and international. "Just continue the research, and fulfill the research criteria that are common in the scientific world, then complete with publications in national and international journals," he said as quoted by Antara, Sunday, April 18.

With the existence of scientific journals, both national and international, he said, all related parties can and are open to conducting studies. "So that it can avoid the assessment that it is not a promotion or even just comments," said a neurologist who graduated from the University of Medicine Faculty. Airlangga (FK Unair). According to Andreas Harry, who is also a volunteer involved in helping to raise nutritional assistance for health workers dealing with COVID-19, if comments are dominant - especially from those who are not in the capacity to study health science - who seem to ask for recognition of the effectiveness of the vaccine, it is more in the counterproductive condition. In addition, related to the Nusantara Vaccine polemic - which was discovered by former Health Minister Terawan Agus Putranto and his team - he also disagrees if there is an opinion that one institution is authorities, such as the Food and Drug Supervisory Agency (BPOM), will inhibit a research that is very nice.

He said that there must be procedural errors or there were procedural deviations from the research principles so that later it was conveyed by the BPOM regarding the Nusantara Vaccine. Regarding the existing polemic, he suggested that dialogue and communication between related parties could be achieved so that a common understanding could be reached, in order to find out. at the same time fixing anything that needs to be completed and perfected. He hopes Terawan Agus Putranto, who he calls his fellow FK Unair alumni - in which Terawan is a graduate of the S-2 Specialization in Radiology, FK Unair, Surabaya (2004) - will succeed in his discovery. a truly scientific vaccine. "Hopefully, he will continue to research the Nusantara Vaccine with scientific standards that can be studied by related parties," said Andreas Harry. Indonesia itself, in the procurement of anti-COVID-19 vaccines, is also in the process of making Red and White Vaccine. In order to accelerate the handling of COVID-19 in Indonesia, the government through a decree President Number 18 of 2020 dated September 3, 2020 has formed a COVID-19 Vaccine Development Team, which is tasked with developing a domestically produced COVID-19 vaccine called the Red and White Vaccine. Domestic vaccines aim to create independence to meet the needs of the COVID-19 vaccine in the future. Red and white vaccine research was carried out by six domestic institutions, namely the Eijikman Institute, LIPI, UI, UGM, ITB and Unair. Meanwhile, for clinical trials, production and distribution are left to the state-owned company PT Bio Farma